TrialBMC medicine2023

A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.